COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03443830
Recruitment Status : Completed
First Posted : February 23, 2018
Last Update Posted : April 10, 2019
Duke-NUS Graduate Medical School
Singapore Clinical Research Institute
National University, Singapore
National University Hospital, Singapore
Information provided by (Responsible Party):
Tychan Pte Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 12, 2018
Actual Study Completion Date : December 4, 2018